Your session is about to expire
← Back to Search
eHealth Self-Monitoring for Depression
N/A
Waitlist Available
Led By Vanessa Panaite, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up date of initiation of psychotherapy up to 30 weeks.
Awards & highlights
Summary
This trial studies how to help Veterans with depression get the care they need. Analysis of medical data & an eHealth intervention will be used to improve engagement in treatment & sustain mental health care.
Who is the study for?
This trial is for Veterans referred to VA mental health clinics for depression treatment. It's open to all ages and genders, but not for those with bipolar or psychotic disorders, substance abuse issues, severe cognitive impairment, unstable life situations, or other severe medical conditions that could affect the study.
What is being tested?
The study aims to develop an eHealth intervention focused on self-monitoring to improve engagement in mental health care among Veterans with depression. Researchers will use VHA data to identify factors linked to poor treatment adherence and test strategies for better engagement.
What are the potential side effects?
Since this trial involves self-monitoring as part of an eHealth intervention rather than medication or invasive procedures, traditional physical side effects are not expected. However, participants may experience emotional discomfort when engaging with their symptoms during self-monitoring.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ date of initiation of psychotherapy up to 30 weeks.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~date of initiation of psychotherapy up to 30 weeks.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acceptability as assessed by rate of initiation and completion of the intervention
Feasibility as assessed by rate of completion of individual tasks within intervention
Other study objectives
Effectiveness of intervention as assessed by rate of depression treatment initiation and adherence
Trial Design
1Treatment groups
Experimental Treatment
Group I: Self-monitoringExperimental Treatment1 Intervention
This research study will evaluate a self-monitoring intervention to increase awareness, provide support, and promote motivation to initiate treatment after referral to mental health. The proposed intervention is a user-driven program delivered online and by mobile text. This will be initially piloted for acceptability among Veterans referred to mental health service for depression treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
self-monitoring
2018
N/A
~140
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,647 Previous Clinical Trials
3,360,040 Total Patients Enrolled
78 Trials studying Depression
19,914 Patients Enrolled for Depression
Vanessa Panaite, PhDPrincipal InvestigatorJames A. Haley Veterans' Hospital, Tampa, FL
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I was recently referred to a VA clinic for depression therapy.My age does not limit my participation.I do not have bipolar or current psychotic disorders.I do not have severe mental health issues or other serious illnesses that could affect the study.I am eligible regardless of my gender or minority status.
Research Study Groups:
This trial has the following groups:- Group 1: Self-monitoring
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger